🇺🇸 FDA
Patent

US 7846954

Heterocyclic derivatives as modulators of ion channels

granted A61PA61P1/00A61P1/04

Quick answer

US patent 7846954 (Heterocyclic derivatives as modulators of ion channels) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61P, A61P1/00, A61P1/04, A61P13/00, A61P13/02